When.com Web Search

Search results

1. Results From The WOW.Com Content Network

2. Which Medications Are FDA-Approved for Weight Loss? - AOL

   www.aol.com/medications-fda-approved-weight-loss...

   Qsymia (Phentermine-Topiramate) Qsymia is a once-daily oral weight loss medication approved for adults and adolescents 12 years and older who meet the BMI criteria. This medicine works on ...

3. Eli Lilly to sell Zepbound directly to consumers without ...

   www.aol.com/eli-lilly-sell-zepbound-directly...

   People who are in need of weight loss medications but do not have insurance coverage will soon have a new way to access one of the popular medications, Zepbound. Eli Lilly, the maker of Zepbound ...

4. Ozempic push for seniors? Some doctors say more people ... - AOL

   www.aol.com/news/ozempic-push-seniors-doctors...

   Some doctors say more people age 65 and over should be on it. Just 9% of older adults age 65 and up say they have taken GLP-1 drugs like Ozempic, Wegovy and Mounjaro, according to recent data from ...

5. Retatrutide - Wikipedia

   en.wikipedia.org/wiki/Retatrutide

   Retatrutide. Retatrutide (LY-3437943) is an experimental drug for obesity developed by American pharmaceutical company Eli Lilly and Company. It is a triple glucagon hormone receptor agonist (GLP-1, GIP, and GCGR receptors). [1] It has been shown to achieve a more than 17.5% mean weight reduction in adults without diabetes but with obesity or ...

6. Anti-obesity medication - Wikipedia

   en.wikipedia.org/wiki/Anti-obesity_medication

   t. e. Orlistat (Xenical), the most commonly used medication to treat obesity and sibutramine (Meridia), a medication that was withdrawn due to cardiovascular side effects. Anti-obesity medication or weight loss medications are pharmacological agents that reduce or control excess body fat. These medications alter one of the fundamental processes ...

7. Phentermine/topiramate - Wikipedia

   en.wikipedia.org/wiki/Phentermine/topiramate

   In the US, the drug label contains warnings for increased heart rate, suicidal behavior and ideation, glaucoma, mood and sleep disorders, creatinine elevation, and metabolic acidosis. Some of these warnings are based on historical observations in epilepsy patients taking topiramate.